Expertise in
14
conditions

Dr. Jashmin K. Patel

Oncology
St. Luke's Regional Medical Center
190 E Bannock St, 
Boise, ID 
Accepting New Patients
Offers Telehealth
17 Years of Experience
Expertise in
14
conditions
St. Luke's Regional Medical Center
190 E Bannock St, 
Boise, ID 

Overview

Jashmin Patel is an Oncologist practicing medicine in Boise, Idaho. She has been practicing medicine for over 17 years.

Dr. Patel is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Pancreatic Cancer, and Familial Pancreatic Cancer.

She is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 4 clinical trials. Dr. Patel is currently accepting new patients.

Graduate Year

2009

Specialties

Oncology

Licenses

Internal Medicine in ID

Hospital Affiliations

St Luke's Elmore Medical Center
St Luke's Nampa Medical Center
St Luke's Regional Medical Center
St Luke's Wood River Medical Center
St Luke's Mccall

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Moda Health
  • EPO
  • PPO
Mountain Health
  • OTHER COMMERCIAL
  • POS
  • PPO
PacificSource
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
SelectHealth
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

St. Luke's Regional Medical Center
190 E Bannock St, Boise, ID 83712

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: August 31, 2026
Intervention Type: Other, Radiation, Procedure, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) a Phase III Trial
DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) a Phase III Trial
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure, Biological, Drug
Study Drugs: Dabrafenib Mesylate, Ipilimumab, Nivolumab, Trametinib Dimethyl Sulfoxide
Study Phase: Phase 3
Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Other, Procedure, Drug
Study Drugs: Atezolizumab, 5-Fluorouracil, Leucovorin, Oxaliplatin
Study Phase: Phase 3
A Randomized Phase 2 Trial of AM0010 in Combination With Pembrolizumab vs. Pembrolizumab Alone as First-Line (1L) Therapy in Patients With Stage IV / Metastatic Wild Type (WT) Non-Small Cell Lung Cancer and Tumors With High Expression of PD-L1 (> 50%)
A Randomized Phase 2 Trial of AM0010 in Combination With Pembrolizumab vs. Pembrolizumab Alone as First-Line (1L) Therapy in Patients With Stage IV / Metastatic Wild Type (WT) Non-Small Cell Lung Cancer and Tumors With High Expression of PD-L1 (> 50%)
Enrollment Status: Terminated
Publish Date: January 20, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 2
View 3 Less Clinical Trials

2 Total Publications

A population-based analysis of outcomes for small cell carcinoma of the breast by tumor stage and the use of radiation therapy.
A population-based analysis of outcomes for small cell carcinoma of the breast by tumor stage and the use of radiation therapy.
Journal: SpringerPlus
Published: February 27, 2015
Similar Doctors
Expertise in
13
conditions
Expertise in
13
conditions
Referral may be required

St. Luke's Regional Medical Center

190 E Bannock St, 
Boise, ID 
 (0.1 miles away)
208-381-4171
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Gerardo Perez is an Oncologist practicing medicine in Boise, Idaho. Dr. Perez is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Ovarian Carcinosarcoma, Bladder Reconstruction, and Hernia Surgery. Dr. Perez is currently accepting new patients.

Expertise in
41
conditions
Expertise in
41
conditions
Referral may be required

St. Luke's Regional Medical Center LTD

100 E Idaho St, 
Boise, ID 
 (0.1 miles away)
208-381-2711
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jonathan Swerdloff is an Oncologist practicing medicine in Boise, Idaho. Dr. Swerdloff is highly rated in 41 conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, and Paget Disease of the Breast. Dr. Swerdloff is currently accepting new patients.

Expertise in
22
conditions
Expertise in
22
conditions
Referral may be required

St. Luke's Regional Medical Center

190 E Bannock St, 
Boise, ID 
 (0.1 miles away)
208-467-6700
Languages Spoken:
English
See accepted insurances

Larry Fiorentino is an Oncologist practicing medicine in Boise, Idaho. Dr. Fiorentino is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Chronic Lymphocytic Leukemia (CLL), Large-Cell Immunoblastic Lymphoma, and Paget Disease of the Breast.

Frequently Asked Questions about Dr. Jashmin K. Patel

How do I make an appointment with Dr. Jashmin K. Patel?

You can book an appointment with Dr. Jashmin K. Patel by calling their office at 208-381-2711. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jashmin K. Patel a top-rated expert for Paget Disease of the Breast?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jashmin K. Patel is classified as an Advanced expert for Paget Disease of the Breast, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jashmin K. Patel specialize in?

While Dr. Jashmin K. Patel is a Oncology, they have specific expertise in Paget Disease of the Breast, Breast Cancer, and Pancreatic Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Jashmin K. Patel participate in research or clinical trials?

Yes. Dr. Jashmin K. Patel has published 2 articles and abstracts on conditions like Paget Disease of the Breast. You can view a list of Dr. Jashmin K. Patel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jashmin K. Patel accept my insurance?

Dr. Jashmin K. Patel accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 208-381-2711 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Patel's expertise for a condition
ConditionClose
      View All 14 Advanced Conditions
      View All 64 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile